Claims
- 1. 1,4-dimethyl-3-(4-hydroxy-3-methoxyphenyl)-2-phenoxy-1,4,2-diazaphospholidin-5-one-2-oxide.
- 2. 1,4-dimethyl-3-(2-furanyl)-2-phenoxy-1,4,2-diazaphospholidin-5-one-2-oxide.
- 3.1,4-dimethyl-2-(4-methylphenoxy)-3-phenyl-1,4,2-diazaphospholidin-5-one-2-oxide.
- 4. 1,4-dimethyl-3-(3,4-dichlorophenyl)-2-phenoxy-1,4,2-diazaphospholidin-5-thione-2-oxide.
- 5. 2-(2-chloroethoxy-1,4-dimethyl-3-phenyl-1,4,2-diazaphospholidin-5-one-2-oxide.
- 6. 2-(2-chloroethoxy)-1,4-dimethyl-3-(3-heptyl)-1,4,2-diazaphospholidin-5-one-2-oxide.
- 7. 2-(2-chloroethoxy)-1,4-dimethyl-3-(2,6-dimethylhepta-1,5-dienyl)-1,4,2-diazaphospholidin-5-one-2-oxide.
- 8. 1,4-dimethyl-2-(2-chloroethoxy)-1,4,2-diazaphospholidin-5-one-2-oxide.
Parent Case Info
The present patent application is a continuation-in-part of Ser. No. 385,933, filed Aug. 6, 1973, which application has been abandoned.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
3551527 |
Weber et al. |
Dec 1970 |
|
Non-Patent Literature Citations (1)
Entry |
Merten et al., Berichte, vol. 102, pp. 2143-2145 (1969). |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
385933 |
Aug 1973 |
|